Egetis Therapeutics AB (EGTX.ST) Q2 2026 Earnings

Apr 29Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.24
-0.21
-0.19
-0.16

Details

Expected EPS
-0.1860852818
Actual EPS
-0.2350550928
Surprise EPS
-0.05
Surprise Percent
-26.32%

Description

⁨Egetis Therapeutics AB⁩ (⁦EGTX.ST⁩) has reported earnings of ⁦-0.2350550928⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts